- Affiliate Assistant Professor, Global Health
Select from the following:
Dr. Seth O’Neal’s research focuses on developing practical and effective strategies to prevent Taenia solium taeniasis/cysticercosis, a preventable cause of epilepsy across much of Latin America, Asia, and Sub-Saharan Africa. His research spans a broad range of disciplines, including field epidemiology, simulation modelling, diagnostics development, clinical and community intervention trials, and implementation research, with active collaborations in UW Department of Global Health. He holds a Visiting Investigator position at Universidad Peruana Cayetano Heredia (UPCH), and served as co-Director for the UPCH Center for Global Health in Tumbes, Peru. Dr. O’Neal is an active research mentor, working closely with trainees from a variety of disciplines and stages, through hands-on mentored research opportunities at the Center in Peru. He trained at Oregon Health & Sciences University (OHSU), where he received his medical degree, residency in preventive medicine, and a Masters of Public Health in Epidemiology and Biostatistics. He is currently on faculty at the OHSU-Portland State University School of Public Health.
- MD, Oregon Health & Sciences University
- MPH, Oregon Health & Sciences University
- Spanish
- Community Health Workers
- Community-Based Participatory Research
- Disease Surveillance
- Environmental Health (incl. Climate Change)
- Epidemiology
- Implementation Science
- Infectious Diseases
- Infectious Diseases (other than STDs)
- Modeling
- Neglected Diseases, Tropical Medicine (incl. Parasites)
- Prevention
- Research
- Zoonotic Diseases and Animal Health
Bonnet G, Pizzitutti F, Gonzales-Gustavson EA, Gabriël S, Pan WK, Garcia HH, Bustos JA, Vilchez P, O'Neal SE. CystiHuman: A model of human neurocysticercosis. PLoS Comput Biol. 2022 May;18(5):e1010118. PMCID: PMC9159625.
O'Neal SE, Pray IW, Vilchez P, Gamboa R, Muro C, Moyano LM, Ayvar V, Gavidia CM, Gilman RH, Gonzalez AE, Garcia HH. Geographically Targeted Interventions versus Mass Drug Administration to Control Taenia solium Cysticercosis, Peru. Emerg Infect Dis. 2021 Sep;27(9):2389-2398. PMCID: PMC8386790.
Pray IW, Pizzitutti F, Bonnet G, Gonzales-Gustavson E, Wakeland W, Pan WK, Lambert WE, Gonzalez AE, Garcia HH, O'Neal SE. Validation of a spatial agent-based model for Taenia solium transmission ("CystiAgent") against a large prospective trial of control strategies in northern Peru. PLoS Negl Trop Dis. 2021 Oct;15(10):e0009885. PMCID: PMC8575314.
Garcia HH, Gonzalez AE, Tsang VC, O'Neal SE, Llanos-Zavalaga F, Gonzalvez G, Romero J, Rodriguez S, Moyano LM, Ayvar V, Diaz A, Hightower A, Craig PS, Lightowlers MW, Gauci CG, Leontsini E, Gilman RH; Cysticercosis Working Group in Peru. Elimination of Taenia solium Transmission in Northern Peru. N Engl J Med. 2016 Jun 16;374(24):2335-44. PMCID: PMC4962610.
O'Neal SE, Flecker RH. Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012. Emerg Infect Dis. 2015 Jun;21(6):969-76. PMCID: PMC4451927.